Status | Study |
Recruiting |
Study Name: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma Condition: Rhabdomyosarcoma Rhabdomyosarcoma- Alveolar Date: 2017-02-02 Interventions: Drug: Dasatinib Once daily on |
Suspended |
Study Name: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma Condition: Alveolar Rhabdomyosarcoma Botryoid-Type Embryonal Rhabdomyosarcoma Date: 2015-10-02 Interventions: Drug: Cyclophosphamide Given I |
Completed |
Study Name: Biomarkers in Patients With Advanced Rhabdomyosarcoma Condition: Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Date: 2012-08-15 Interventions: Other: Laboratory Biomarker Analysis Correlative studies |
Completed |
Study Name: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Condition: Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Date: 2010-01-22 Interventions: Biological: Cixutumumab Given |
Active, not recruiting |
Study Name: Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma Condition: Neuroblastoma Sarcoma Rhabdomyosarco Date: 2009-06-17 Interventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes |
Completed |
Study Name: Collecting Tumor Samples From Patients With Gynecological Tumors Condition: Borderline Ovarian Clear Cell Tumor Borderline Ovarian Serous Tumor Date: 2009-05-09 Interventions: Other: Laboratory Biomarker Analysis Correlative studies |
Recruiting |
Study Name: Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome Condition: Pleuropulmonary Blastoma Cystic Nephroma Sertoli-Leydig Ce Date: 2007-11-29 |
Active, not recruiting |
Study Name: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Condition: Adult Malignant Mesenchymoma Adult Rhabdomyosarcoma Childh Date: 2006-07-19 Interventions: Drug: Irinotecan Hydrochloride |
Recruiting |
Study Name: Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma Condition: Sarcoma Date: 2005-10-25 Interventions: Biological: dactinomycin Drug: cyclophosph |
Recruiting |
Study Name: Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma Condition: Sarcoma Date: 2005-10-25 Interventions: Biological: dactinomycin Drug: cyclophosph |